Natural Killer Cell Epigenetic Reprogramming in Tumors and Potential for Cancer Immunotherapy

References

• De Keukeleire SJ , VermassenT , HilgertE , CreytensD , FerdinandeL , RotteyS. Immuno-oncological biomarkers for squamous cell cancer of the head and neck: current state of the art and future perspectives. Cancers13(7), 1714 (2021).
   PubMed Web of Science ®Google Scholar
• June CH , O’ConnorRS , KawalekarOU , GhassemiS , MiloneMC. CAR T cell immunotherapy for human cancer. Science359(6382), 1361–1365 (2018).
   PubMed Web of Science ®Google Scholar
• Maali A , GholizadehM , Feghhi-NajafabadiSet al. Nanobodies in cell-mediated immunotherapy: on the road to fight cancer. Front. Immunol.14, 1012841 (2023).
   PubMed Web of Science ®Google Scholar
• Wang Z , GuanD , WangS , ChaiLYA , XuS , LamK-P. Glycolysis and oxidative phosphorylation play critical roles in natural killer cell receptor-mediated natural killer cell functions. Front. Immunol.11, 202 (2020).
   PubMed Web of Science ®Google Scholar
• Xu J , NiuT. Natural killer cell-based immunotherapy for acute myeloid leukemia. J. Hematol. Oncol.13(1), 167 (2020).
   PubMed Web of Science ®Google Scholar
• Melero I , RouzautA , MotzGT , CoukosG. T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy. Cancer Discov.4(5), 522–526 (2014).
   PubMed Web of Science ®Google Scholar
• Jones BS , LambLS , GoldmanF , DiStasi A. Improving the safety of cell therapy products by suicide gene transfer. Front. Pharmacol.5, 254 (2014).
   PubMedGoogle Scholar
• Shi L , LiK , GuoYet al. Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer. Proc. Natl Acad. Sci. USA115(46), 11808–11813 (2018).
   PubMed Web of Science ®Google Scholar
• Lazarova M , SteinleA. Impairment of NKG2D-mediated tumor immunity by TGF-β. Front. Immunol.10, 2689 (2019).
   PubMed Web of Science ®Google Scholar
• Merino AM , KimH , MillerJS , CichockiF. Unraveling exhaustion in adaptive and conventional NK cells. J. Leucoc. Biol.108(4), 1361–1368 (2020).
   PubMed Web of Science ®Google Scholar
• Chu J , GaoF , YanMet al. Natural killer cells: a promising immunotherapy for cancer. J. Transl. Med.20(1), 240 (2022).
   PubMed Web of Science ®Google Scholar
• Vivier E , TomaselloE , BaratinM , WalzerT , UgoliniS. Functions of natural killer cells. Nat. Immunol.9(5), 503–510 (2008).
   PubMed Web of Science ®Google Scholar
• Chiossone L , DumasP-Y , VienneM , VivierE. Natural killer cells and other innate lymphoid cells in cancer. Nat. Rev. Immunol.18(11), 671–688 (2018).
   PubMed Web of Science ®Google Scholar
• Rubnitz JE , InabaH , RibeiroRCet al. NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. J. Clin. Oncol.28(6), 955 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang Y , WallaceDL , DeLara CMet al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology121(2), 258–265 (2007).
   PubMed Web of Science ®Google Scholar
• Seillet C , BrossayL , VivierE. Natural killers or ILC1s? That is the question. Curr. Opin. Immunol.68, 48–53 (2021).
   PubMed Web of Science ®Google Scholar
• Gianchecchi E , DelfinoDV , FierabracciA. Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases?Front. Immunol.12, 616853 (2021).
   PubMed Web of Science ®Google Scholar
• Campbell KS , HasegawaJ. Natural killer cell biology: an update and future directions. J. Allergy Clin. Immunol.132(3), 536–544 (2013).
   PubMed Web of Science ®Google Scholar
• Melsen JE , LugthartG , LankesterAC , SchilhamMW. Human circulating and tissue-resident CD56(bright) natural killer cell populations. Front. Immunol.7, 262 (2016).
   PubMed Web of Science ®Google Scholar
• Goh W , HuntingtonND. Regulation of murine natural killer cell development. Front. Immunol.8, 130 (2017).
   PubMed Web of Science ®Google Scholar
• Myers JA , SchirmD , BendzickLet al. Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion. JCI Insight7(15), e150079 (2022).
   PubMed Web of Science ®Google Scholar
• O’Sullivan TE , SunJC , LanierLL. Natural killer cell memory. Immunity43(4), 634–645 (2015).
   PubMed Web of Science ®Google Scholar
• Martinet L , SmythMJ. Balancing natural killer cell activation through paired receptors. Nat. Rev. Immunol.15(4), 243–254 (2015).
   PubMed Web of Science ®Google Scholar
• Villa-Álvarez M , Sordo-BahamondeC , Lorenzo-HerreroSet al. Ig-like transcript 2 (ILT2) blockade and lenalidomide restore NK cell function in chronic lymphocytic leukemia. Front. Immunol.9, 2917 (2018).
   PubMed Web of Science ®Google Scholar
• Wu S-Y , FuT , JiangY-Z , ShaoZ-M. Natural killer cells in cancer biology and therapy. Mol. Cancer19(1), 120 (2020).
   PubMed Web of Science ®Google Scholar
• Hammer Q , RückertT , BorstEMet al. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. Nat. Immunol.19(5), 453–463 (2018).
   PubMed Web of Science ®Google Scholar
• Brodin P , LakshmikanthT , JohanssonS , KärreK , HöglundP. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. Blood113(11), 2434–2441 (2009).
   PubMed Web of Science ®Google Scholar
• Voskoboinik I , SmythMJ , TrapaniJA. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol.6(12), 940–952 (2006).
   PubMed Web of Science ®Google Scholar
• Regis S , DonderoA , SpaggiariGMet al. miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells. Cell. Signal.98, 110415 (2022).
   PubMed Web of Science ®Google Scholar
• Leijonhufvud C , SchlumsH , StikvoortA , UhlinM , BrycesonYT , CarlstenM. Comprehensive exploration of NK cell education in ADCC triggered by a monoclonal antibody or a bispecific killer engager molecule (BiKE). Blood140(Suppl. 1), 8350–8350 (2022).
   Google Scholar
• Deniz G , AkdisM , AktasE , BlaserK , AkdisCA. Human NK1 and NK2 subsets determined by purification of IFN-γ-secreting and IFN-γ-nonsecreting NK cells. Eur. J. Immunol.32(3), 879–884 (2002).
   PubMed Web of Science ®Google Scholar
• Brillantes M , BeaulieuAM. Memory and memory-like NK cell responses to microbial pathogens. Front. Cell. Infect. Microbiol.10, 102 (2020).
   PubMed Web of Science ®Google Scholar
• Lopez-Vergès S , MilushJM , SchwartzBSet al. Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl Acad. Sci. USA108(36), 14725–14732 (2011).
   PubMed Web of Science ®Google Scholar
• Paul S , KulkarniN , Shilpi , LalG. Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells. Oncoimmunology5(12), e1235106 (2016).
   PubMed Web of Science ®Google Scholar
• Peng Y-P , ZhuY , ZhangJ-Jet al. Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer. J. Transl. Med.11, 262 (2013).
   PubMed Web of Science ®Google Scholar
• Beldi-Ferchiou A , LambertM , DogniauxSet al. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma. Oncotarget7(45), 72961 (2016).
   PubMedGoogle Scholar
• Wiesmayr S , WebberSA , MacedoCet al. Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD. Eur. J. Immunol.42(2), 541–550 (2012).
   PubMed Web of Science ®Google Scholar
• Li F , WeiH , WeiHet al. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology144(2), 392–401 (2013).
   PubMed Web of Science ®Google Scholar
• Bi J , TianZ. NK cell exhaustion. Front. Immunol.8, 760 (2017).
   PubMed Web of Science ®Google Scholar
• Zhang C , LiuY. Targeting NK cell checkpoint receptors or molecules for cancer immunotherapy. Front. Immunol.11, 1295 (2020).
   PubMed Web of Science ®Google Scholar
• Hsu J , HodginsJJ , MaratheMet al. Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade. J. Clin. Invest.128(10), 4654–4668 (2018).
   PubMed Web of Science ®Google Scholar
• Xia M , WangB , WangZ , ZhangX , WangX. Epigenetic regulation of NK cell-mediated antitumor immunity. Front. Immunol.12, 672328 (2021).
   PubMed Web of Science ®Google Scholar
• Lanier LL . NK cell recognition. Annu. Rev. Immunol.23, 225–274 (2005).
   PubMed Web of Science ®Google Scholar
• Huang HT , SuSC , ChiouTJet al. DNA methylation-mediated Siglec-7 regulation in natural killer cells via two 5′ promoter CpG sites. Immunology160(1), 38–51 (2020).
   PubMed Web of Science ®Google Scholar
• Chan H-W , KuragoZB , StewartCAet al. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med.197(2), 245–255 (2003).
   PubMed Web of Science ®Google Scholar
• Gao X-N , LinJ , WangL-L , YuL. Demethylating treatment suppresses natural killer cell cytolytic activity. Mol. Immunol.46(10), 2064–2070 (2009).
   PubMed Web of Science ®Google Scholar
• Santourlidis S , TrompeterH-I , WeinholdSet al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol.169(8), 4253–4261 (2002).
   PubMed Web of Science ®Google Scholar
• Luetke-Eversloh M , HammerQ , DurekPet al. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog.10(10), e1004441 (2014).
   PubMed Web of Science ®Google Scholar
• Schenk A , BlochW , ZimmerP. Natural killer cells – an epigenetic perspective of development and regulation. Int. J. Mol. Sci.17(3), 326 (2016).
   PubMed Web of Science ®Google Scholar
• Schlums H , CichockiF , TesiBet al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity42(3), 443–456 (2015).
   PubMed Web of Science ®Google Scholar
• Luetke-Eversloh M , CicekBB , SiracusaFet al. NK cells gain higher IFN-γ competence during terminal differentiation. Eur. J. Immunol.44(7), 2074–2084 (2014).
   PubMed Web of Science ®Google Scholar
• Zhao N-H , QianY , WuC-Set al. Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma. Biomark. Med.13(13), 1093–1105 (2019).
   PubMed Web of Science ®Google Scholar
• Rogers SL , RouhiA , TakeiF , MagerDL. A role for DNA hypomethylation and histone acetylation in maintaining allele-specific expression of mouse NKG2A in developing and mature NK cells. J. Immunol.177(1), 414–421 (2006).
   PubMed Web of Science ®Google Scholar
• Li Y , WangJ , YinJet al. Chromatin state dynamics during NK cell activation. Oncotarget8(26), 41854 (2017).
   PubMedGoogle Scholar
• Zhang Y , SunZ , JiaJet al. Overview of histone modification. Adv. Exp. Med. Biol.1283, 1–16 (2021).
   PubMed Web of Science ®Google Scholar
• Black JC , Van RechemC , WhetstineJR. Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol. Cell48(4), 491–507 (2012).
   PubMed Web of Science ®Google Scholar
• Cichocki F , FelicesM , MccullarVet al. Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J. Immunol.187(12), 6171–6175 (2011).
   PubMed Web of Science ®Google Scholar
• Fernández-Sánchez A , BaraganoRaneros A , CarvajalPalao Ret al. DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells. Epigenetics8(1), 66–78 (2013).
   PubMed Web of Science ®Google Scholar
• Chang S , AuneTM. Histone hyperacetylated domains across the Ifng gene region in natural killer cells and T cells. Proc. Natl Acad. Sci. USA102(47), 17095–17100 (2005).
   PubMed Web of Science ®Google Scholar
• Ogbomo H , MichaelisM , KreuterJ , DoerrHW , CinatlJJr. Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett.581(7), 1317–1322 (2007).
   PubMed Web of Science ®Google Scholar
• Zimmer P , BaumannFT , BlochWet al. Impact of exercise on pro inflammatory cytokine levels and epigenetic modulations of tumor-competitive lymphocytes in non-Hodgkin-lymphoma patients – randomized controlled trial. Eur. J. Haematol.93(6), 527–532 (2014).
   PubMed Web of Science ®Google Scholar
• Zimmer P , BlochW , SchenkAet al. Exercise-induced natural killer cell activation is driven by epigenetic modifications. Int. J. Sports Med.36(06), 510–515 (2015).
   PubMedGoogle Scholar
• Eddy JL , KrukowskiK , JanusekL , MathewsHL. Glucocorticoids regulate natural killer cell function epigenetically. Cell. Immunol.290(1), 120–130 (2014).
   PubMed Web of Science ®Google Scholar
• Yin J , LeavenworthJW , LiYet al. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity. Proc. Natl Acad. Sci. USA112(52), 15988–15993 (2015).
   PubMed Web of Science ®Google Scholar
• Bugide S , GreenMR , WajapeyeeN. Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells. Proc. Natl Acad. Sci. USA115(15), E3509–E3518 (2018).
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S , GrangerV , RakMet al. Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death Differ.26(10), 2100–2114 (2019).
   PubMed Web of Science ®Google Scholar
• Rasid O , ChevalierC , CamarasaTM-N , FittingC , CavaillonJ-M , HamonMA. H3K4me1 supports memory-like NK cells induced by systemic inflammation. Cell Rep.29(12), 3933–3945 e3933 (2019).
   PubMed Web of Science ®Google Scholar
• Fabian MR , SonenbergN. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol.19(6), 586–593 (2012).
   PubMed Web of Science ®Google Scholar
• Pesce S , GreppiM , FerrettiEet al. miRNAs in NK cell-based immune responses and cancer immunotherapy. Front. Cell Dev. Biol.8, 119 (2020).
   PubMed Web of Science ®Google Scholar
• Sullivan RP , LeongJW , SchneiderSEet al. MicroRNA-15/16 antagonizes Myb to control NK cell maturation. J. Immunol.195(6), 2806–2817 (2015).
   PubMed Web of Science ®Google Scholar
• Orange JS . Formation and function of the lytic NK-cell immunological synapse. Nat. Rev. Immunol.8(9), 713–725 (2008).
   PubMed Web of Science ®Google Scholar
• Gordon SM , ChaixJ , RuppLJet al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity36(1), 55–67 (2012).
   PubMed Web of Science ®Google Scholar
• Mundy-Bosse BL , ScovilleSD , ChenLet al. MicroRNA-29b mediates altered innate immune development in acute leukemia. J. Clin. Invest.126(12), 4404–4416 (2016).
   PubMed Web of Science ®Google Scholar
• Regis S , CaliendoF , DonderoAet al. TGF-β1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells. Front. Immunol.8, 868 (2017).
   PubMed Web of Science ®Google Scholar
• Kim T-D , LeeSU , YunSet al. Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity. Blood118(20), 5476–5486 (2011).
   PubMed Web of Science ®Google Scholar
• Tato CM , MasonN , ArtisDet al. Opposing roles of NF-κB family members in the regulation of NK cell proliferation and production of IFN-γ. Int. Immunol.18(4), 505–513 (2006).
   PubMed Web of Science ®Google Scholar
• Ni F , GuoC , SunRet al. MicroRNA transcriptomes of distinct human NK cell populations identify miR-362-5p as an essential regulator of NK cell function. Sci. Rep.5(1), 1–11 (2015).
   Google Scholar
• Cheng YQ , RenJP , ZhaoJet al. Micro RNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection. Immunology145(4), 485–497 (2015).
   PubMed Web of Science ®Google Scholar
• Ma Y , GongJ , LiuYet al. MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D. Life Sci.151, 174–181 (2016).
   PubMed Web of Science ®Google Scholar
• Abdelrahman MM , FawzyIO , BassiouniAAet al. Enhancing NK cell cytotoxicity by miR-182 in hepatocellular carcinoma. Hum. Immunol.77(8), 667–673 (2016).
   PubMed Web of Science ®Google Scholar
• Wang P , GuY , ZhangQet al. Identification of resting and type I IFN-activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity. J. Immunol.189(1), 211–221 (2012).
   PubMed Web of Science ®Google Scholar
• Liu S , ChenL , ZengYet al. Suppressed expression of miR-378 targeting gzmb in NK cells is required to control dengue virus infection. Cell. Mol. Immunol.13(5), 700–708 (2016).
   PubMed Web of Science ®Google Scholar
• Davies G , LockeS , WrightPet al. Identification of bidirectional promoters in the human KIR genes. Genes Immun.8(3), 245–253 (2007).
   PubMed Web of Science ®Google Scholar
• Pesce S , SquillarioM , GreppiMet al. New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR-146a-5p in the regulation of KIR expression. Front. Immunol.9, 2360 (2018).
   PubMed Web of Science ®Google Scholar
• Nutalai R , GaudieriS , JumnainsongA , LeelayuwatC. Regulation of KIR3DL3 expression via miRNA. Genes10(8), 603 (2019).
   PubMed Web of Science ®Google Scholar
• Wang X , LiJ , DongKet al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell. Signal.27(3), 443–452 (2015).
   PubMed Web of Science ®Google Scholar
• Xu S , TaoZ , HaiBet al. miR-424 (322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint. Nat. Commun.7(1), 11406 (2016).
   PubMedGoogle Scholar
• Donatelli SS , ZhouJ-M , GilvaryDLet al. TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells. Proc. Natl Acad. Sci. USA111(11), 4203–4208 (2014).
   PubMed Web of Science ®Google Scholar
• Chen E-B , ZhouZ-J , XiaoKet al. The miR-561-5p/CX3CL1 signaling axis regulates pulmonary metastasis in hepatocellular carcinoma involving CX3CR1+ natural killer cells infiltration. Theranostics9(16), 4779 (2019).
   PubMed Web of Science ®Google Scholar
• Herberman RB , NunnME , LavrinDH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer16(2), 216–229 (1975).
   PubMed Web of Science ®Google Scholar
• Chiang SC , TheorellJ , EntesarianMet al. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Blood121(8), 1345–1356 (2013).
   PubMed Web of Science ®Google Scholar
• Deguine J , BreartB , LemaîtreF , DiSanto JP , BoussoP. Intravital imaging reveals distinct dynamics for natural killer and CD8+ T cells during tumor regression. Immunity33(4), 632–644 (2010).
   PubMed Web of Science ®Google Scholar
• Imai K , MatsuyamaS , MiyakeS , SugaK , NakachiK. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet356(9244), 1795–1799 (2000).
   PubMed Web of Science ®Google Scholar
• Hinshaw DC , ShevdeLA. The tumor microenvironment innately modulates cancer progression. Cancer Res.79(18), 4557–4566 (2019).
   PubMed Web of Science ®Google Scholar
• Yang C , ChengH , ZhangYet al. Anergic natural killer cells educated by tumor cells are associated with a poor prognosis in patients with advanced pancreatic ductal adenocarcinoma. Cancer Immunol. Immunother.67(12), 1815–1823 (2018).
   PubMed Web of Science ®Google Scholar
• Tang Y-P , XieM-Z , LiK-Z , LiJ-L , CaiZ-M , HuB-L. Prognostic value of peripheral blood natural killer cells in colorectal cancer. BMC Gastroenterol.20(1), 31 (2020).
   PubMed Web of Science ®Google Scholar
• Rathore AS , GoelMM , MakkerA , KumarS , SrivastavaAN. Is the tumor infiltrating natural killer cell (NK-TILs) count in infiltrating ductal carcinoma of breast prognostically significant?Asian Pac. J. Cancer Prev.15(8), 3757–3761 (2014).
   PubMedGoogle Scholar
• Okada K , SadahiroS , ChanLFet al. The number of natural killer cells in the largest diameter lymph nodes is associated with the number of retrieved lymph nodes and lymph node size, and is an independent prognostic factor in patients with stage II colon cancer. Oncology95(5), 288–296 (2018).
   PubMed Web of Science ®Google Scholar
• Dorner BG , SmithHR , FrenchARet al. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J. Immunol.172(5), 3119–3131 (2004).
   PubMed Web of Science ®Google Scholar
• Best SA , HessJB , Souza-Fonseca-GuimaraesFet al. Harnessing natural killer immunity in metastatic SCLC. J. Thorac. Oncol.15(9), 1507–1521 (2020).
   PubMed Web of Science ®Google Scholar
• Merino A , ZhangB , DoughertyPet al. Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming. J. Clin. Invest.129(9), 3770–3785 (2019).
   PubMed Web of Science ®Google Scholar
• Lambert AW , PattabiramanDR , WeinbergRA. Emerging biological principles of metastasis. Cell168(4), 670–691 (2017).
   PubMed Web of Science ®Google Scholar
• Groh V , WuJ , YeeC , SpiesT. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature419(6908), 734–738 (2002).
   PubMed Web of Science ®Google Scholar
• Fauriat C , MalletF , OliveD. Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma. Leukemia20(4), 732–733 (2006).
   PubMed Web of Science ®Google Scholar
• Schleypen JS , Von GeldernM , WeißEHet al. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. Int. J. Cancer106(6), 905–912 (2003).
   PubMed Web of Science ®Google Scholar
• Holt D , MaX , KunduN , FultonA. Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4. Cancer Immunol. Immunother.60(11), 1577–1586 (2011).
   PubMed Web of Science ®Google Scholar
• Inoue T , AdachiK , KawanaKet al. Cancer-associated fibroblast suppresses killing activity of natural killer cells through downregulation of poliovirus receptor (PVR/CD155), a ligand of activating NK receptor. Int. J. Oncol.49(4), 1297–1304 (2016).
   PubMed Web of Science ®Google Scholar
• Li T , YangY , HuaXet al. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO. Cancer Lett.318(2), 154–161 (2012).
   PubMed Web of Science ®Google Scholar
• Bommarito D , MartinA , ForcadeE , NastkeM-D , RitzJ , BellucciR. Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway. Cancer Immunol. Immunother.65(3), 355–366 (2016).
   PubMed Web of Science ®Google Scholar
• Al Absi A , WurzerH , GuerinCet al. Actin cytoskeleton remodeling drives breast cancer cell escape from natural killer–mediated cytotoxicity. Cancer Res.78(19), 5631–5643 (2018).
   PubMed Web of Science ®Google Scholar
• Neo SY , YangY , RecordJet al. CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment. J. Clin. Invest.130(3), 1185–1198 (2020).
   PubMed Web of Science ®Google Scholar
• Kao SC , ChengYY , WilliamsMet al. Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma. J. Thorac. Oncol.12(9), 1421–1433 (2017).
   PubMed Web of Science ®Google Scholar
• Guo W , TanW , LiuSet al. MiR-570 inhibited the cell proliferation and invasion through directly targeting B7-H1 in hepatocellular carcinoma. Tumor Biol.36(11), 9049–9057 (2015).
   PubMedGoogle Scholar
• Shen J , PanJ , DuCet al. Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer. Cell Death Dis.8(4), e2740–e2740 (2017).
   PubMed Web of Science ®Google Scholar
• Wu Y , KuangDM , PanWDet al. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Hepatology57(3), 1107–1116 (2013).
   PubMed Web of Science ®Google Scholar
• Espinoza JL , TakamiA , YoshiokaKet al. Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions. Haematologica97(9), 1295 (2012).
   PubMed Web of Science ®Google Scholar
• Ansell SM , LesokhinAM , BorrelloIet al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. N. Engl. J. Med.372(4), 311–319 (2015).
   PubMed Web of Science ®Google Scholar
• Sanmamed MF , ChenL. A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell175(2), 313–326 (2018).
   PubMed Web of Science ®Google Scholar
• Parkhurst MR , RileyJP , DudleyME , RosenbergSA. Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin. Cancer Res.17(19), 6287–6297 (2011).
   PubMed Web of Science ®Google Scholar
• Krause SW , GastparR , AndreesenRet al. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase I trial. Clin. Cancer Res.10(11), 3699–3707 (2004).
   PubMed Web of Science ®Google Scholar
• Geller MA , CooleyS , JudsonPLet al. A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. Cytotherapy13(1), 98–107 (2011).
   PubMed Web of Science ®Google Scholar
• Klingemann H , BoisselL , ToneguzzoF. Natural killer cells for immunotherapy – advantages of the NK-92 cell line over blood NK cells. Front. Immunol.7, 91 (2016).
   PubMed Web of Science ®Google Scholar
• Eguizabal C , ZenarruzabeitiaO , MongeJet al. Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective. Front. Immunol.5, 439 (2014).
   PubMed Web of Science ®Google Scholar
• Woll PS , GrzywaczB , TianXet al. Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood113(24), 6094–6101 (2009).
   PubMed Web of Science ®Google Scholar
• Maali A , MaroufiF , SadeghiFet al. Induced pluripotent stem cell technology: trends in molecular biology, from genetics to epigenetics. Epigenomics13(8), 631–647 (2021).
   PubMedGoogle Scholar
• Zhang C , OberoiP , OelsnerSet al. Chimeric antigen receptor-engineered NK-92 cells: an off-the-shelf cellular therapeutic for targeted elimination of cancer cells and induction of protective antitumor immunity. Front. Immunol.8, 533 (2017).
   PubMed Web of Science ®Google Scholar
• Daher M , RezvaniK. Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering. Curr. Opin. Immunol.51, 146–153 (2018).
   PubMed Web of Science ®Google Scholar
• Maroufi F , MaaliA , Abdollahpour-AlitappehM , AhmadiMH , AzadM. CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy. Epigenomics12(20), 1845–1859 (2020).
   PubMed Web of Science ®Google Scholar
• Zingg D , Arenas-RamirezN , SahinDet al. The histone methyltransferase Ezh2 controls mechanisms of adaptive resistance to tumor immunotherapy. Cell Rep.20(4), 854–867 (2017).
   PubMed Web of Science ®Google Scholar
• Schenk A , PulvererW , KoliamitraCet al. Acute exercise increases the expression of KIR2DS4 by promoter demethylation in NK cells. Int. J. Sports Med.40(01), 62–70 (2019).
   PubMedGoogle Scholar
• Schmiedel BJ , ArélinV , GruenebachF , KruschM , SchmidtSM , SalihHR. Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation. Int. J. Cancer128(12), 2911–2922 (2011).
   PubMed Web of Science ®Google Scholar
• Sohlberg E , PfefferleA , AnderssonS , BaumannBC , Hellström-LindbergE , MalmbergK-J. Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome. Oncotarget6(33), 34178 (2015).
   PubMed Web of Science ®Google Scholar
• Hicks KC , FantiniM , DonahueRNet al. Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types. Oncoimmunology7(11), e1466018 (2018).
   PubMed Web of Science ®Google Scholar
• Jennings VA , ScottGB , RoseAMet al. Potentiating oncolytic virus-induced immune-mediated tumor cell killing using histone deacetylase inhibition. Mol. Ther.27(6), 1139–1152 (2019).
   PubMed Web of Science ®Google Scholar
• Zhu S , DenmanCJ , CobanogluZSet al. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. Pharm. Res.32(3), 779–792 (2015).
   PubMed Web of Science ®Google Scholar
• Pace M , WilliamsJ , KuriokaAet al. Histone deacetylase inhibitors enhance CD4 T cell susceptibility to NK cell killing but reduce NK cell function. PLoS Pathog.12(8), e1005782 (2016).
   PubMed Web of Science ®Google Scholar
• Rossi LE , AvilaDE , SpallanzaniRGet al. Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression. J. Leukoc. Biol.91(2), 321–331 (2012).
   PubMed Web of Science ®Google Scholar
• Shi X , LiM , CuiMet al. Epigenetic suppression of the antitumor cytotoxicity of NK cells by histone deacetylase inhibitor valproic acid. Am. J. Cancer Res.6(3), 600 (2016).
   PubMed Web of Science ®Google Scholar
• Sun W , LvS , LiH , CuiW , WangL. Enhancing the anticancer efficacy of immunotherapy through combination with histone modification inhibitors. Genes9(12), 633 (2018).
   PubMed Web of Science ®Google Scholar
• Bailey CP , FigueroaM , GangadharanAet al. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma. Neuro Oncol.22(9), 1302–1314 (2020).
   PubMed Web of Science ®Google Scholar
• Bailey CP , FigueroaM , GangadharanA , LeeDA , ChandraJ. Scaffolding LSD1 inhibitors impair NK cell metabolism and cytotoxic function through depletion of glutathione. Front. Immunol.11, 2196 (2020).
   PubMed Web of Science ®Google Scholar
• Stern-Ginossar N , GurC , BitonMet al. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat. Immunol.9(9), 1065–1073 (2008).
   PubMed Web of Science ®Google Scholar
• Yee D , ShahKM , ColesMC , SharpTV , LagosD. MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells. J. Biol. Chem.292(50), 20683–20693 (2017).
   PubMed Web of Science ®Google Scholar
• Allen TM , CullisPR. Liposomal drug delivery systems: from concept to clinical applications. Adv. Drug Deliv. Rev.65(1), 36–48 (2013).
   PubMed Web of Science ®Google Scholar
• Yang L , SunJ , LiuQet al. Synergetic functional nanocomposites enhance immunotherapy in solid tumors by remodeling the immunoenvironment. Adv. Sci.6(8), 1802012 (2019).
   Web of Science ®Google Scholar
• Neviani P , WisePM , MurtadhaMet al. Natural killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms. Cancer Res.79(6), 1151–1164 (2019).
   PubMed Web of Science ®Google Scholar
• Fabbri M . Natural killer cell-derived vesicular miRNAs: a new anticancer approach?Cancer Res.80(1), 17–22 (2020).
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M , SiljanderPR-M , AndreuZet al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles4(1), 27066 (2015).
   PubMed Web of Science ®Google Scholar
• Parolini I , FedericiC , RaggiCet al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem.284(49), 34211–34222 (2009).
   PubMed Web of Science ®Google Scholar
• Federici C , ShahajE , CecchettiSet al. Natural-killer-derived extracellular vesicles: immune sensors and interactors. Front. Immunol.11, 262 (2020).
   PubMed Web of Science ®Google Scholar
• Lugini L , CecchettiS , HuberVet al. Immune surveillance properties of human NK cell-derived exosomes. J. Immunol.189(6), 2833–2842 (2012).
   PubMed Web of Science ®Google Scholar
• Hollenbach PW , NguyenAN , BradyHet al. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines. PLoS ONE5(2), e9001 (2010).
   PubMed Web of Science ®Google Scholar
• Jabbour E , Garcia-ManeroG , BattyNet al. Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy. Cancer116(16), 3830–3834 (2010).
   PubMed Web of Science ®Google Scholar
• Cabrero M , JabbourE , RavandiFet al. Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: retrospective analysis of survival after long-term follow-up. Leuk. Res.39(5), 520–524 (2015).
   PubMed Web of Science ®Google Scholar
• Moon JH , KimSN , KangBWet al. Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment. Ann. Hematol.89, 681–689 (2010).
   PubMed Web of Science ®Google Scholar
• Mahfouz RZ , JankowskaA , EbrahemQet al. Increased CDA expression/activity in males contributes to decreased cytidine analog half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapygender, cytidine deaminase, and 5-aza/decitabine. Clin. Cancer Res.19(4), 938–948 (2013).
   PubMed Web of Science ®Google Scholar
• Sun Y , ZhouB , MaoFet al. HOXA9 reprograms the enhancer landscape to promote leukemogenesis. Cancer Cell34(4), 643–658 e645 (2018).
   PubMed Web of Science ®Google Scholar
• Tikellis G , DwyerT , PaltielOet al. The International Childhood Cancer Cohort Consortium (I4C): a research platform of prospective cohorts for studying the aetiology of childhood cancers. Paediatr. Perinat. Epidemiol.32(6), 568–583 (2018).
   PubMed Web of Science ®Google Scholar
• Craddock CF , HoultonAE , QuekLSet al. Outcome of azacitidine therapy in acute myeloid leukemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature. Clin. Cancer Res.23(21), 6430–6440 (2017).
   PubMed Web of Science ®Google Scholar
• Sekeres MA , OthusM , ListAFet al. Randomized phase II study of azacitidine alone or in combination with lenalidomide or with vorinostat in higher-risk myelodysplastic syndromes and chronic myelomonocytic leukemia: North American Intergroup Study SWOG S1117. J. Clin. Oncol.35(24), 2745 (2017).
   PubMed Web of Science ®Google Scholar
• Burke MJ , KostadinovR , SpostoRet al. Decitabine and vorinostat with chemotherapy in relapsed pediatric acute lymphoblastic leukemia: a TACL pilot study. Clin. Cancer Res.26(10), 2297–2307 (2020).
   PubMed Web of Science ®Google Scholar